CDSCO, states begin joint checks of drug-making units across India

Objective of drug regulation is to ensure safety, efficacy, and quality of drugs

A large drug firm has 12-15 therapy divisions, and if each launches a few drugs, the company brings to the market 30-50 brands a year.

Sohini Das Mumbai
Amid controversy surrounding India-made drugs that allegedly caused the deaths of children in the Gambia, the Central Drugs Standard Control Organisation (CDSCO) has started conducting inspections of identified drug manufacturing units jointly with state authorities across India.

The idea of the joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country, the Union Ministry of Health said on Tuesday.

However, this is not the first time such widespread joint inspections have happened in India. 

First Published: Dec 27 2022 | 9:23 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to